Evaluating Wearable Smart Sensors for Continuous Measurement of Vital Signs in ICU Patients

Launched by ANN & ROBERT H LURIE CHILDREN'S HOSPITAL OF CHICAGO · Jan 20, 2021

Keywords

ClinConnect Summary

This clinical trial is focused on testing new wearable smart sensors that can continuously monitor vital signs in patients in the Intensive Care Unit (ICU). These devices are designed to be safe to use on the skin and will help doctors keep a close eye on important health information without causing any discomfort to the patients. The study aims to improve how healthcare providers track the health of children who are experiencing serious medical conditions, particularly those born prematurely.

To participate in this study, patients need to be under 18 years old and admitted to one of the four ICUs at Lurie Children's or Prentice Women's Hospital. There is also an option for non-ICU patients who are willing to come for a one-time visit. However, patients who have certain skin conditions or are considered too unstable by their medical team cannot join. Participants can expect to wear the smart sensors for monitoring, which should help in providing better care during their hospital stay. This trial is currently recruiting participants, and it represents an exciting step towards enhancing patient monitoring in critical care settings.

Gender

ALL

Eligibility criteria

• Inclusion Criteria-ICU Population:
• • Admitted to one of the four ICUs at Lurie Children's or Prentice Women's Hospital
• • Under 18 years of age
• • Inclusion Criteria-Non-ICU Population
• • Under 18 years of age
• • Willing to visit the Center for Autonomic Medicine in Pediatrics (CAMP) for a one time study visit
• Exclusion Criteria-ICU Population:
• • A skin abnormality that would potentially increase the risk of device
• • 18 years of age or older
• • Determined by an attending physician or bedside care team to be too unstable (patient) or experiencing too much stress (family)
• Exclusion Criteria-Non-ICU Population:
• • A skin abnormality that would potentially increase risk of device use
• • 18 years of age or older